INSM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Insmed Inc

NASDAQ | INSM

206.74

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$43.62B

Market Cap

-

P/E Ratio

-6.19

EPS

$209.77

52 Week High

$60.40

52 Week Low

HEALTHCARE

Sector

INSM Chart

Recent Chart
Price Action

INSM Technicals

Tags:

INSM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $278M
Total Revenue $364M
Cost Of Revenue $86M
Costof Goods And Services Sold $86M
Operating Income -$878M
Selling General And Administrative $461M
Research And Development $598M
Operating Expenses $1.2B
Investment Income Net -
Net Interest Income -$85M
Interest Income $2.2M
Interest Expense $85M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $11M
Income Before Tax -$910M
Income Tax Expense $3.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$914M
Comprehensive Income Net Of Tax -
Ebit -$830M
Ebitda -$819M
Net Income -$914M

Revenue & Profitability

Earnings Performance

INSM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $2B
Total Current Assets $1.6B
Cash And Cash Equivalents At Carrying Value $555M
Cash And Short Term Investments $555M
Inventory $99M
Current Net Receivables $52M
Total Non Current Assets $404M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $59M
Intangible Assets Excluding Goodwill $59M
Goodwill $136M
Investments -
Long Term Investments -
Short Term Investments $879M
Other Current Assets $37M
Other Non Current Assets -
Total Liabilities $1.7B
Total Current Liabilities $298M
Current Accounts Payable $73M
Deferred Revenue -
Current Debt -
Short Term Debt $16M
Total Non Current Liabilities $1.4B
Capital Lease Obligations $45M
Long Term Debt $1.1B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.3B
Other Current Liabilities $208M
Other Non Current Liabilities $306M
Total Shareholder Equity $285M
Treasury Stock -
Retained Earnings -$4.4B
Common Stock $1.8M
Common Stock Shares Outstanding $164M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$684M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $11M
Capital Expenditures $22M
Change In Receivables -
Change In Inventory -$17M
Profit Loss -
Cashflow From Investment -$583M
Cashflow From Financing $1.3B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$914M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $278M
Total Revenue $364M
Cost Of Revenue $86M
Costof Goods And Services Sold $86M
Operating Income -$878M
Selling General And Administrative $461M
Research And Development $598M
Operating Expenses $1.2B
Investment Income Net -
Net Interest Income -$85M
Interest Income $2.2M
Interest Expense $85M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $11M
Income Before Tax -$910M
Income Tax Expense $3.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$914M
Comprehensive Income Net Of Tax -
Ebit -$830M
Ebitda -$819M
Net Income -$914M

INSM News

INSM Profile

Insmed Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Insmed Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, specializing in the development of novel therapies for rare and serious diseases, primarily focusing on pulmonary and infectious conditions. Its leading therapeutic candidate, ARIKAYCE, is designed to treat treatment-refractory Mycobacterium avium complex lung disease, highlighting the company’s commitment to addressing significant unmet medical needs. With a robust pipeline and a strong emphasis on research and development, Insmed is well-positioned for future growth and innovation in the biopharmaceutical sector, reflecting its ongoing dedication to improving health outcomes for patients with rare diseases.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
AMZE
+33.81%
$0.52
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
VALE
+0.63%
$12.59
C
+1.31%
$102.50
IREN
+0.12%
$48.51
CRCA
+22.96%
$4.52
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
GOOG
-0.66%
$318.15
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
BTBT
+4.31%
$2.42
ACHR
+3.40%
$7.74
PSTV
+6.68%
$0.59
CCCS
+0.96%
$7.32
ORCL
-1.74%
$201.38
BB
+1.75%
$4.07
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
AMZE
+33.81%
$0.52
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
VALE
+0.63%
$12.59
C
+1.31%
$102.50
IREN
+0.12%
$48.51
CRCA
+22.96%
$4.52
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
GOOG
-0.66%
$318.15
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
BTBT
+4.31%
$2.42
ACHR
+3.40%
$7.74
PSTV
+6.68%
$0.59
CCCS
+0.96%
$7.32
ORCL
-1.74%
$201.38
BB
+1.75%
$4.07
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.